| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.1 | 0.3 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | -0.19 | 0.3 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.054 | 0.3 |
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | -0.055 | 0.3 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.061 | 0.3 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.3 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.049 | 0.3 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.038 | 0.3 |